-
HDFC Bank
744.50 726.75(%) -
Bluestone Jewel
742.30 400.40(%) -
Bharti Airtel
1,931.00 1,745.00(%) -
Oracle Fin.Serv.
9,950.00 6,232.20(%) -
Tanla Platforms
656.70 765.75(%) -
Gandhar Oil Ref.
283.85 245.00(%) -
IndusInd Bank
1,002.50 710.85(%) -
United Spirits
1,435.00 1,489.00(%) -
Eternal
296.15 368.40(%) -
Adani Green
1,392.35 767.00(%) -
SBI Funds Mgt.
597.30 625.00(%) -
HEG
675.90 685.10(%) -
Kalyan Jewellers
588.60 327.15(%) -
Dhabriya Poly.
472.00 490.00(%) -
Maruti Suzuki
13,579.85 17,371.60(%) -
SRF
2,700.00 2,313.75(%) -
Bandhan Bank
169.65 134.30(%) -
Reliance Industries
1,277.85 1,253.65(%) -
NTPC Green Ene.
99.59 119.93(%) -
Bajaj Auto
11,320.00 11,025.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Jubilant Pharmova Ltd Pharmaceuticals - Indian - Bulk Drugs
- Jubilant Bhartia
- BSE Code : 592.0
- ISIN : INE700A01033
-
Today’s Low
974.05 -
Today’s High
1,006.85
-
Open
1,006.85 -
Perv Close
1,007.80 -
52W Low
786.05 -
52W High
1,248.00
Key Indicators
-
P/E(TTM)
0.00
-
Mar.Cap (₹Cr.)
15,754.77
-
Div & Yield %
0.50
-
Book Value(₹)
145.16
-
Debt-Equity Ratio
-1.87
-
AGM Date
22-Jul-2026
-
EPS
1.97
-
P/E Ratio
0.00
Financials Ratios
-
Debt-Equity Ratio
0.68
-
Mar.Cap (₹Cr.)
15,754.77
-
RONW (%)
0.76
-
ROCE (%)
6.37
Score Board
-
Equity (₹ in Cr.)
15.93
-
BV (₹)
145.20
-
Sales( ₹ in Cr.)
263.40
-
NP (in Cr.)
31.37
-
NP Var(%)
28.0
-
Div%
500.0
-
CPS (₹)
2.30
-
EPS (₹)
2.00
-
Traded Value (₹ in Lakhs)
15,820.08
-
52 Week High
1,248.00
-
52 Week Low
786.05
-
Price BSE
993.0
-
Price NSE
989.00
-
Market Capital( in Cr.)
15,820.08
-
P/C Ratio
423.30
-
P/E Ratio
504.20
-
Price Vs.BV
2.00
-
26-Jun-2026( 12:03)
Hot Pursuit - Jubil... - Jubilant Generics is a subsidi...
-
19-Jun-2026( 09:33)
Hot Pursuit - Jubil... - The inspection concluded with...
-
19-Jun-2026( 09:16)
Corporate News - USFDA... - <P>Jubilant Pharmova announced...
-
22-May-2026( 07:29)
Corporate News - Board... - Jubilant Pharmova announced th...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 745.70 | 784.70 | 810.10 | 725.73 | 2,709.50 | 3,139.90 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 745.70 | 784.70 | 810.10 | 725.73 | 2,709.50 | 3,139.90 |
| Other Income | 99.60 | 103.40 | 137.90 | 126.16 | 47.88 | 173.23 |
| Stock Adjustments | 6.70 | -39.00 | -3.50 | 40.61 | -55.21 | 108.32 |
| Total Income | 852.00 | 849.10 | 944.50 | 892.50 | 2,702.17 | 3,421.45 |
| EXPENDITURE : | ||||||
| Raw Materials | 282.50 | 316.50 | 411.10 | 372.89 | 1,395.15 | 1,792.74 |
| Power and Fuel Cost | 78.00 | 68.40 | 75.40 | 62.31 | 280.40 | 369.20 |
| Employee Cost | 203.00 | 190.00 | 167.30 | 163.64 | 220.67 | 264.90 |
| Other Manufacturing Expenses | 60.60 | 59.60 | 49.00 | 39.80 | 216.91 | 269.07 |
| Selling and Administration Expenses | 91.10 | 88.60 | 93.00 | 111.59 | 100.02 | 143.14 |
| Miscellaneous Expenses | 16.30 | 6.10 | 7.70 | 9.65 | 14.07 | 39.96 |
| Employee Benefit Expenses | 203.00 | 190.00 | 167.30 | 163.64 | 220.67 | 264.90 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 731.50 | 729.20 | 803.50 | 759.88 | 2,227.23 | 2,879.02 |
| Operating Profit | 120.50 | 119.90 | 141.00 | 132.62 | 474.94 | 542.44 |
| Interest | 29.80 | 29.90 | 18.50 | 10.99 | 101.80 | 136.20 |
| Gross Profit | 90.70 | 90.00 | 122.50 | 121.63 | 373.14 | 406.24 |
| Depreciation | 53.10 | 48.30 | 43.20 | 36.91 | 99.97 | 107.40 |
| Profit Before Tax | 37.60 | 41.70 | 79.30 | 84.72 | 273.17 | 298.84 |
| Current Tax | 19.80 | 6.80 | 13.80 | 14.28 | 45.44 | 26.13 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -1.40 | 3.30 | 15.60 | -10.05 | 13.25 | -48.43 |
| Reported Net Profit | 19.20 | 31.60 | 49.90 | 80.49 | 214.48 | 321.14 |
| Extraordinary Items | -5.30 | -0.76 | 0.25 | 0.02 | -0.19 | -4.92 |
| Adjusted Net Profit | 24.50 | 32.36 | 49.65 | 80.47 | 214.67 | 326.06 |
| Adjustment below Net Profit | 3.30 | 0.00 | -0.70 | 0.81 | -212.82 | -3.49 |
| P & L Balance brought forward | 1,075.60 | 1,123.60 | 1,154.00 | 1,152.37 | 1,153.26 | 986.93 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 79.60 | 79.60 | 79.60 | 79.64 | 0.00 | 151.32 |
| P & L Balance carried down | 1,018.50 | 1,075.60 | 1,123.60 | 1,154.03 | 1,154.92 | 1,153.26 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 500.00 | 500.00 | 500.00 | 500.00 | 500.00 | 500.00 |
| Dividend Per Share(Rs) | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Earnings Per Share-Unit Curr | 1.21 | 1.99 | 3.14 | 5.05 | 13.46 | 20.16 |
| Earnings Per Share(Adj)-Unit Curr | 1.21 | 1.99 | 3.14 | 5.05 | 13.46 | 17.49 |
| Book Value | 145.79 | 149.34 | 151.86 | 153.11 | 80.51 | 163.67 |
| Book Value(Adj)-Unit Curr | 145.79 | 149.34 | 151.86 | 153.11 | 80.51 | 142.03 |
